Growth Metrics

Protalix BioTherapeutics (PLX) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 20.11%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.71%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 31.42%
10 Protalix BioTherapeutics 164.49 Mn 153.70 Mn 29.62 Mn 105.65%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 105.65%
Dec 31, 2025 46.37%
Sep 30, 2025 23.17%
Jun 30, 2025 8.38%
Mar 31, 2025 3.26%
Dec 31, 2024 41.45%
Sep 30, 2024 52.04%
Jun 30, 2024 -35.77%
Mar 31, 2024 32.97%
Dec 31, 2023 34.48%
Sep 30, 2023 -21.75%
Jun 30, 2023 37.38%
Mar 31, 2023 23.26%
Dec 31, 2022 7.17%
Sep 30, 2022 -37.13%
Jun 30, 2022 -11.45%
Mar 31, 2022 6.65%
Dec 31, 2021 -14.05%
Sep 30, 2021 -29.35%
Jun 30, 2021 40.42%
Mar 31, 2021 -1.89%
Dec 31, 2020 -34.44%
Sep 30, 2020 29.97%
Jun 30, 2020 3.01%
Mar 31, 2020 6.43%
Dec 31, 2019 24.71%
Sep 30, 2019 -0.26%
Jun 30, 2019 25.06%
Mar 31, 2019 7.86%
Dec 31, 2018 11.30%
Sep 30, 2018 49.61%
Jun 30, 2018 -20.91%
Mar 31, 2018 -15.53%
Mar 31, 2017 -0.64%
Dec 31, 2016 -85.78%
Sep 30, 2016 25.10%
Jun 30, 2016 -12.00%
Mar 31, 2016 2.37%
Dec 31, 2015 -75.50%
Sep 30, 2015 -4.48%
Jun 30, 2015 -33.06%
Mar 31, 2015 4.04%
Mar 31, 2014 -9.28%
Dec 31, 2013 29.79%
Sep 30, 2013 8.14%